3

OWNERSHIP DOCUMENT

Company: Mineralys Therapeutics, Inc.
Filed: February 9, 2023
Period of Report: February 9, 2023
Accession Number: 0001104659-23-017791

View Document ↗ View on SEC.gov ↗